BioNexus Gene Lab Corp. (BGLC) vs Intelligent Group Limited (INTJ)

A side-by-side comparison of BioNexus Gene Lab Corp. and Intelligent Group Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGLC vs INTJ

growth of $100 · dividends reinvested · last 3y
BGLC -83.9% (-45.6%/yr)INTJ -95.7% (-64.9%/yr)BGLC compounded faster over this window
050100150Start $10020252026$16$4
BGLC INTJ

BGLC vs INTJ: by the numbers

  • •BGLC is the larger company ($3M vs $3M market cap).
  • •Both run net losses; BGLC's is the smaller (-82.36% vs -143.97% net margin).
  • •INTJ grew revenue faster over the past five years (10.26% vs -31.68% CAGR).

Metrics side by side

Valuation

MetricBGLCINTJ
P/S ratio0.950.98
P/B ratio0.380.23

Profitability

MetricBGLCINTJ
Gross margin11.64%63.72%
Operating margin-42.54%-108.20%
Net margin-82.36%-143.97%
ROE-33.11%-33.54%
ROIC-32.71%-19.30%

Growth (annualized)

MetricBGLCINTJ
Revenue CAGR (5Y)-31.68%10.26%
Total return CAGR (5Y)-61.00%N/A

Frequently asked

Which has grown faster, BGLC or INTJ?
Over the past five years, INTJ grew revenue faster — BGLC at a -31.68% CAGR versus INTJ at 10.26%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.